Augmentation of cognitive-behavioural therapy for obsessive-compulsive and anxiety disorders: a protocol for a systematic review and meta-analysis

被引:0
作者
Torbecke, Jonathan [1 ]
Langhammer, Till [1 ]
Mewes, Lisa [1 ]
Lueken, Ulrike [1 ,2 ]
Fendel, Johannes Caspar [3 ]
机构
[1] Humboldt Univ, Dept Psychol, Berlin, Germany
[2] German Ctr Mental Hlth DZPG, Partner Site Berlin Potsdam, Potsdam, Germany
[3] Univ Freiburg, Med Fac, Med Ctr, Dept Psychosomat Med & Psychotherapy, Freiburg im Breisgau, Germany
来源
BMJ OPEN | 2024年 / 14卷 / 10期
关键词
Anxiety disorders; Systematic Review; Meta-Analysis; QUALITY-OF-LIFE; RANDOMIZED CLINICAL-TRIAL; FAMILY INTERVENTION; MENTAL-DISORDERS; PUBLICATION BIAS; REMISSION; COMORBIDITY; CONSENSUS; ABSOLUTE; BURDEN;
D O I
10.1136/bmjopen-2024-090431
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction While cognitive-behavioural therapy (CBT) for obsessive-compulsive disorder (OCD) and anxiety disorders (ADs) has been proven to be effective and is commonly recommended, a considerable proportion of patients remain symptomatic, do not respond to treatment or discontinue it. Thus, augmentation strategies aimed at enhancing CBT outcomes are essential to reduce the burden of OCD and ADs on patients and society. Various augmentation strategies for CBT in OCD and ADs have been investigated, yet it remains unclear if they show robust beneficial effects beyond first-line CBT. With this systematic review and meta-analysis, we will provide an overview and critically assess the efficacy of non-pharmacological augmentation strategies in addition to first-line CBT treatment for symptom reduction, response rates and dropout rates in individuals with OCD or ADs.Methods and analysis We will screen PubMed, Embase, PsycArticles, PsycInfo, CINAHL, PSYNDEX and Cochrane Register of Controlled Trials without restrictions on publication dates or languages. Additionally, forward, and backward searches of included studies and systematic reviews will be conducted. Two reviewers will independently screen the studies, extract data and assess the methodological quality of the studies. We will exclusively include randomised controlled trials. The primary outcomes will be symptom severity and response rates. Dropout rates will serve as a secondary outcome. Moreover, we will provide a narrative review of the results. We will use subgroup and meta-regression analyses to identify potential moderators and sources of between-study heterogeneity. We will use the Grading of Recommendations Assessment, Development and Evaluation system to assess the overall quality of evidence.Ethics and dissemination Ethical approval is not required. Results will be published in a peer-reviewed journal.PROSPERO registration number CRD42024561027.
引用
收藏
页数:7
相关论文
共 67 条
  • [1] American Psychiatric Association, 1994, DIAGNOSTIC STAT MANU
  • [2] Obsessive-compulsive severity spectrum in the community:: prevalence, comorbidity, and course
    Angst, J
    Gamma, A
    Endrass, J
    Goodwin, R
    Ajdacic, V
    Eich, D
    Rössler, W
    [J]. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2004, 254 (03) : 156 - 164
  • [3] Defining response and remission in anxiety disorders: Toward an integrated approach
    Bandelow, Borwin
    [J]. CNS SPECTRUMS, 2006, 11 (10) : 21 - 28
  • [4] Bandelow B, 2015, DIALOGUES CLIN NEURO, V17, P327
  • [5] The global burden of anxiety disorders in 2010
    Baxter, A. J.
    Vos, T.
    Scott, K. M.
    Ferrari, A. J.
    Whiteford, H. A.
    [J]. PSYCHOLOGICAL MEDICINE, 2014, 44 (11) : 2363 - 2374
  • [6] An information processing model of anxiety: Automatic and strategic processes
    Beck, AT
    Clark, DA
    [J]. BEHAVIOUR RESEARCH AND THERAPY, 1997, 35 (01) : 49 - 58
  • [7] Basics of meta-analysis: I2 is not an absolute measure of heterogeneity
    Borenstein, Michael
    Higgins, Julian P. T.
    Hedges, Larry V.
    Rothstein, Hannah R.
    [J]. RESEARCH SYNTHESIS METHODS, 2017, 8 (01) : 5 - 18
  • [8] Individual-Level Prediction of Exposure Therapy Outcome Using Structural and Functional MRI Data in Spider Phobia: A Machine-Learning Study
    Chavanne, Alice V.
    Meinke, Charlotte
    Langhammer, Till
    Roesmann, Kati
    Boehnlein, Joscha
    Gathmann, Bettina
    Herrmann, Martin J.
    Junghoefer, Markus
    Klahn, Luisa
    Schwarzmeier, Hanna
    Seeger, Fabian R.
    Siminski, Niklas
    Straube, Thomas
    Dannlowski, Udo
    Lueken, Ulrike
    Leehr, Elisabeth J.
    Hilbert, Kevin
    [J]. DEPRESSION AND ANXIETY, 2023, 2023
  • [9] tDCS-Augmented in vivo exposure therapy for specific fears: A randomized clinical trial
    Cobb, Adam R.
    O'Connor, Patrick
    Zaizar, Eric
    Caulfield, Kevin
    Gonzalez-Lima, Francisco
    Telch, Michael J.
    [J]. JOURNAL OF ANXIETY DISORDERS, 2021, 78
  • [10] Absolute and relative outcomes of psychotherapies for eight mental disorders: a systematic review and meta-analysis
    Cuijpers, Pim
    Miguel, Clara
    Ciharova, Marketa
    Harrer, Mathias
    Basic, Djordje
    Cristea, Ioana A.
    de Ponti, Nino
    Driessen, Ellen
    Hamblen, Jessica
    Larsen, Sadie E.
    Matbouriahi, Minoo
    Papola, Davide
    Pauley, Darin
    Plessen, Constantin Y.
    Pfund, Rory A.
    Setkowski, Kim
    Schnurr, Paula P.
    van Ballegooijen, Wouter
    Wang, Yingying
    Riper, Heleen
    van Straten, Annemieke
    Sijbrandij, Marit
    Furukawa, Toshi A.
    Karyotaki, Eirini
    [J]. WORLD PSYCHIATRY, 2024, 23 (02) : 267 - 275